Skip to main content
. 2022 Jan 20;13(2):3350–3361. doi: 10.1080/21655979.2022.2027181

Table 3.

Drug likeliness properties of the Apigenin analogues by swissAdme, osiris and Molinspiration

Drug likeness
properties
Boceprevir Apigenin Apigenin 7-glucoside-4’-p-coumarate Apigenin 7-glucoside-4’-trans-caffeate Apigenin 7-O-beta-D-glucoside (Cosmosiin)
Bioavaibility and
drug-scorea
         
Molecular weight g/mol 519.68 270.24 578.52 594.52 432.38
cLogP 1.38 2.34 2.11 1.76 0.35
Solubility −4.02 −2.86 −4.58 −4.29 −2.74
TPSA 150.7 86.99 192.4 212.6 166.1
Druglikness −8.76 1.21 −3.55 −2.7 −2.29
Drug-score 0.11 0.47 0.12 0.13 0.44
Druglikness b          
GPCR ligand 0.50 −0.07 −0.04 −0.09 0.1
Ion channel modulator 0.04 −0.09 −0.49 −0.55 −0.01
Kinase inhibitor −0.03 0.18 −0.12 −0.21 0.14
Nuclear receptor ligand 0.07 0.34 0.07 −0.02 0.31
Protease inhibitor 1.41 −0.25 −0.04 −0.06 0.02
Enzyme inhibitor 0.31 0.26 0.14 0.07 0.43
Pharmacokinetics c          
GI absorption Low High Low Low Low
BBB permeant No No No No No
P-gp substrate Yes No No No Yes
CYP1A2 inhibitor No Yes No No No
CYP2C19 inhibitor No No No No No
CYP2C9 inhibitor No No Yes Yes No
CYP2D6 inhibitor No Yes No No No
CYP3A4 inhibitor Yes Yes No No No

GI: Gastrointestinal absorption; BBB: blood brain barrier; P-gp: Permeability Glycoprotein; CYP: Cytochrome P450; a = Osiris; b = Molinspiration; c = SwissAdme.